abstract: Allelic variants of the detoxification genes that have impaired biotransformation functions may increase susceptibility to reproductive toxicity leading to endometriosis, recurrent miscarriage (RM) or poor pregnancy outcome. In the present study, we have investigated CYP1A1, CYP2D6, GSTT1, GSTP1 and GSTM1, which are involved in the phase I and phase II detoxification systems, in relation to their role in the etiology of unexplained RMs. In a case-control study, we have investigated 200 females with RM and 300 age and ethnically matched healthy controls with successful reproductive history from North India. The frequencies of phase I wild-type genotypes of CYP1A1 and CYP2D6 in RM cases were 0.56 and 0.60, whereas in controls these were 0.68 and 0.65, respectively (both P , 0.05). The GSTM1 nullgenotype frequencies were 0.66 and 0.84 among RM cases and controls, respectively, the GSTT1 null-genotype frequencies were 0.52 and 0.45 (P , 0.005) and the GSTP1 variant allele frequencies were 0.23 and 0.20, respectively. In conclusion, we observed significant protective effects of phase I wild-type genotypes and association of the GSTT1 null genotype with RM. Through combined analyses we have highlighted the importance of the balance of phase I/phase II detoxification systems, in the etiology of RM.
Introduction
Genetic variability and epigenetic factors affect reproduction and fertility from gametogenesis to birth. Recurrent spontaneous miscarriage (or RM) is the loss of three or more consecutive pregnancies, affecting 1% of couples trying to conceive (Rai and Regan, 2006) . RM remains unexplained in up to 80% of cases after investigation, suggesting the possibility of genetic causes. A number of genetic studies have been carried out over the recent years pertaining to an association between RM and genetic polymorphisms related to metabolic enzymes (Zusterzeel et al., 2000; Sata et al., 2003a; b, 2005) , cytokines (Reid et al., 2001; Unfried et al., 2001; Wang et al., 2002a, b; Saijo et al., 2004b) , coagulation factors (Wramsby et al., 2000; Pihusch et al., 2001) , methylenetetrahydrofolate reductase (Lissak et al., 1999; Wramsby et al., 2000; Pihusch et al., 2001) , histocompatibility antigens (Aldrich et al., 2001; Tripathi et al., 2004) and natural killer cell receptors (Wang et al., 2007; Hiby et al., 2008; Faridi et al., 2009) .
For the establishment of a successful pregnancy, an adequate blood supply to the implantation site is crucial among many other factors.
The maternal circulation through the placenta is more restricted during the first few weeks of gestation whereas it rises sharply to its full level at 10 -12 weeks of gestation, i.e. towards the end of the first trimester (Jauniaux et al., 2000) . During this period, there is an increased oxidative load in the placenta which facilitates events such as embryonic differentiation and development. During pregnancy, the placenta is a major source of oxidative stress which may occur as a result of an impaired balance between the oxidation and antioxidation (Gitto et al., 2002) . The placental oxidative stress may prove lethal to the developing embryo in case of excessive oxidative load or inefficient antioxidant defenses which scavenge the load. The risk of miscarriage is enhanced by a variety of environmental factors such as pollutants, as well as lifestyle factors such as stress, smoking, alcohol consumption etc. This may as well be modified by individual genetic variations in metabolic detoxification activities.
Enzymes belonging to the glutathione S-transferase (GST) and cytochrome P450 (CYP) families are involved in a two-stage detoxification process of a wide range of environmental toxins and carcinogens. Most potentially toxic compounds require activation by phase I enzymes, such as cytochrome P450-1A1 (CYP1A1, or aryl hydrocarbon hydroxylase) and P450-2D6 (CYP2D6, or debrisoquine hydroxylase), to become an ultimate reactive compound (Conney, 1982 ). These activated forms may then be subjected to detoxification by phase II enzymes, especially GST. Experimental evidence has shown the expression of CYP1A1 and CYP2D6, among the other members of the CYP family, in the placenta during the first trimester (Hakkola et al., 1996; Wadelius et al., 1997) . The glutathione/GST system, on the other hand, is one of the most important systems involved in the metabolism and detoxification of reactive oxygen species, xenobiotics and carcinogens (Beckett and Hayes, 1993) .
Polymorphisms in the genes encoding biotransformation enzymes may affect the levels of oxidative stress in the placenta as a result of an imbalance between the phase I/phase II detoxification systems. The MspI polymorphism (*2A allele) in the CYP1A1 gene is known to cause the high-inducible phenotype (Petersen et al., 1990; Cosma et al., 1993) , although the exact mechanism is not known. A decrease in the activity of CYP2D6 has been attributed to two major polymorphisms in the gene: the 2637deletion (*3) and the G1934A transition (*4) (Bartsch et al., 2000) . Seven GST gene families encoding cytosolic enzymes have been described. Phenotypic absence of enzyme activity is due to inheritance of a homozygous deletion of the whole gene, i.e. the 'null' genotype in case of GSTM and GSTT. GSTP1 is the major isoform of GSTs found in the follicular microenvironment (Knapen et al., 1999a, b) . A functional polymorphism at codon 105 (Ile/Val) in the GSTP1 gene producing a less functional variant has been reported to be associated with increased risk of RM (Zusterzeel et al., 2000) .
There have been several studies pertaining to the phase I and phase II detoxification systems gene polymorphisms in different diseases especially those related to susceptibility to various forms of cancer (Demir et al., 2005; Anantharaman et al., 2007; Sabitha et al., 2008) , type 2 diabetes (Nowier et al., 2009) and coronary artery disease (Girisha et al., 2004; Abu-Amero et al., 2006) . To date there have been only few studies pertaining to the association of phase I and phase II detoxification gene polymorphisms with unexplained recurrent miscarriage. Zusterzeel et al. (2000) reported in a study of 187 Caucasian patients that the polymorphic variant of GSTP1 was significantly associated with increased risk of RM. On the other hand, through a series of Japanese case-control studies (involving 115 cases), it has been shown that the risk of RM was significantly associated with the variant genotypes of CYP1A2 (Sata et al., 2005) , CYP17 (Sata et al., 2003a) and GSTM1 (Sata et al., 2003b) , whereas no association of the disease was found with the variant genotypes of Ah receptor, CYP1A1, CYP1A2 or CYP1B1 (Saijo et al., 2004a, b) . Among the Indian subjects there is only a single report involving 160 RM patients from South India (Suryanarayana et al., 2004) . The authors reported a significant association of the CYP1A1 variant allele with RM whereas no association was found with other polymorphisms (CYP2D6, GSTT1, GSTM1 or GSTP1), or when the polymorphisms were analyzed in combinations.
Therefore, in order to investigate whether or not there is a genetic association of the biotransformation enzymes and the phase I/phase II balance on the outcome of pregnancy, we have studied the polymorphisms CYP1A1*2 (T6235C; ile462val), CYP2D6*4 (G1934A), GSTP1 (A313G; ile105val) and GSTT1 and GSTM1 null genotypes in 200 RM patients from North India. We have compared our results with ethnically matched parous control women (n ¼ 300) with at least two live births and no history of previous miscarriages or any other pregnancy related complications. To the best of our knowledge, this is the first study from this part of the country.
Materials and Methods

Genomic DNA samples
All the samples were collected from patients attending the out-patients' department of Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, and Queen Mary Hospital of CSM Medical University, Lucknow (UP) India, for the evaluation of recurrent miscarriages. All of them had a history of at least three spontaneous miscarriages (mean 4, range 3 -7) and no previous history of successful pregnancy. The detailed screening and selection criterion of RM patients as well as controls has been mentioned elsewhere (Faridi et al., 2009) . Of all the initially screened 513 individuals, 39% (n ¼ 200) had no known cause of recurrent miscarriage and were included in this study. All RM patients selected were primary aborters, not having any live child and belonged to four different caste groups: upper caste hindus (Brahmin, Vaishya, Kayastha and Kshatriya), backward class (Scheduled caste/tribe and other backward classes), Muslims (Shiya and Sunni) and others (Sindhi, Sikh, Jain and Christians). The patient's detailed clinical information was recorded prior to the inclusion in this study (data not shown). The control group consisted of 300 healthy parous women of the same ethnic distribution as that of RM patients (Supplementary data, Table S1 ) with at least two live births and with no history of miscarriage, preeclampsia, ectopic pregnancy or preterm delivery (Table I ). All the subjects included in this study belong to the eastern Uttar Pradesh province of North India and fall within the same linguistic group (Indo European speakers) (Zhao et al., 2009 ). Blood samples (5 ml) from controls and RM women were collected in EDTA coated collection vials and DNA was extracted using Qiagen DNA extraction kits. This study was approved by the ethics committees of SGPGIMS and Queen Mary Hospital, CSM medical University, Lucknow. Written informed consent to participate in this study was obtained from all the individuals.
Genotype analyses
Genotype analyses of CYP1A1, CYP2D6 and GSTP1 were performed based on the restriction digestion of PCR amplified products whereas those of GSTM1 and GSTT1 were performed in duplex PCR reaction systems based on primers and reaction conditions as per Table II . Table S1 ; # Smoking and alcohol consumption status: never. (Suryanarayana et al., 2004; Cho et al., 2005) . In each reaction, 50 ng of genomic DNA was amplified in10 ml of PCR buffer [67 mM Tris-HCl, pH 8.8, 16 mM (NH 4 ) 2 SO 4 , 2 mM MgCl 2 , 0.01% Tween-20, 100 mM dNTPs) containing 0.5 U of Taq DNA polymerase. All reactions were conducted in an oil-free thermal cycler (PTC 200 Thermal Cyclers, BioRad Inc.) The amplification products were electrophoresed on 2% agarose gels containing ethidium bromide with a migrating distance of 3 cm, and the product bands were visualized under ultraviolet light. The presence of functional GSTT1 and GSTM1 genes was determined by a band of the expected size. Individuals were determined null for a GSTT1 or GSTM1 gene when a band of the expected size was absent in the presence of the positive internal control band (an exon 7 fragment of CYP1A1). Variant alleles of CYP1A1 and GSTP1 were characterized by a gain of restriction site upon digestion with MspI and Alw261, respectively, whereas in case of CYP2D6, the variant allele was determined by the deletion of a BstNI restriction site.
Statistical analysis
Allele and genotype frequencies were determined by PopGen v16. Frequency differences between the RM and control groups were tested for significance using Fisher's exact test with Bonferroni correction. The magnitude of the effect was estimated by odds ratios and their 95% confidence intervals (Windows 11.0.0.2001; SPSS Inc.) . Logistic regression was used to test the association between the variant as well as wild-type genotypes and the prevalence of recurrent miscarriage. P-values less than or equal to 0.05 were considered significant.
Results
DNA samples obtained from 200 females with RM and 300 females with a successful pregnancy history were analyzed for the variant single nucleotide polymorphisms (SNPs) in GSTP1, CYP1A1 and CYP2D6 and null genotypes in GSTM1 and GSTT1. The case and control groups were similar with respect to age and ethnicity (Table I and Supplementary data, Table S1 ). None of the women included in the present study were either smokers or alcohol consumers. In order to establish if the genes included in this study were subject to ethnic variations, we performed the stratification analysis. For this purpose, all the markers under study were analyzed for the allele and genotype frequencies among different caste groups (irrespective of case-control status) for statistical significance at the 95% confidence interval using Fisher's exact test with Bonferroni correction. Upon carrying out the detailed analysis, there were no significant differences observed in these genes regardless of the case -control status (Supplementary data, Table S2 ).
The frequencies of various polymorphic alleles and genotypes in the cases and controls, along with the relevant statistical parameters for comparison, are presented in Tables III and IV .
Analysis of phase I gene polymorphisms
Distributions of the CYP1A1 and CYP2D6 polymorphism are shown in Table III . The genotype and allele frequency data revealed that wildtype CYP1A1 allele was protective in nature. The genotype homozygous for Ile462 allele (TT) was higher in the control group (68%) as compared with RM group (56.5%) reaching statistical significance. It was interesting to note that genotypes having at least one Val462 allele were significantly higher in the RM patients group (P ¼ 0.0398, OR ¼ 1.50, CI ¼ 1.03-2.19). The BstNI polymorphism distinguishes CYP2D6 into extreme metabolizers (EM; wt/wt), intermediate metabolizers (IM; wt/*4) and poor metabolizers (PM; *4/*4) of various drugs and xenobiotic compounds. The *4 allele frequency was indeed significantly higher amongst the RM patients group (25.2%) as compared with control group (15.8%). Upon combined analysis of phase I genes we found that the combined frequency of wild-type CYP1A1 (val/val) and CYP2D6 (wt/wt) genotypes was significantly lower among the RM individuals (31%) than in controls (53%).
Analysis of phase II gene polymorphisms
Frequency distributions of the GSTM1, GSTT1 and GSTP1 genotypes among the RM and control groups are presented in Table IV . No significant association of the GSTM1 null genotype or the GSTP1 variant allele was found with the recurrent miscarriages. The frequencies of GSTM1 null alleles were 33% in patients and 28% in controls and those of GSTP1 variants (ile/val and val/val combined) were 40 and 35% in patients and controls, respectively. The GSTT1 null genotype, on the other hand, was found to be significantly higher in RM group (26%) as compared with controls (15%), (P ¼ 0.0034, OR ¼ 1.99, CI ¼ 1.27 -3.12). When we carried out the combined analysis of the phase II genes, we observed that the GSTT1 null genotypes when present either in combination with GSTM1 null genotypes or GSTP1 variant alleles, confer a higher risk of the disease (approximately 4-fold) in both the combinations. GSTP1 variant allele when present in combination with GSTM1 null variant did not show any Genetic variability in detoxification genes and RM association with RM. There was however, a very strong association of the RM group with GSTT1 null, GSTM1 null and GSTP1 variant alleles when combined, compounding to a greater than 7-fold risk.
Combined association of phase I and phase II systems with RM
Upon combined analysis of phase I and phase II gene polymorphisms, we observed that the all-wild-type combination (A1, D1, P1, M1 and T1) was higher in controls (40%) than in patients (30.5%) reaching statistical significance (P ¼ 0.0365; OR ¼ 0.65; 95% CI 0.45 -0.96).
On the other hand the rarer combination of all variant genotypes (A0, D0, P0, M0 and T0) was higher in patients (4.5%) than in controls (2%), but this difference did not reach statistical significance. CYP1A1 and GSTP1 variants in combination with wild-type genotypes of CYP2D6, GSTT1 and GSTM1 were significantly higher being 20.5 and 12.3% in patients and controls, respectively (P ¼ 0.0193; OR ¼ 1.83; 95% CI 1.12-2.9). One prominent feature of the genotype profiles which were present only in patients was that six out of seven patients had at least one phase I variant allele in combination with one or more phase II null or mutant genotypes. Two RM patients were found to have all the wild-type alleles except for a GSTT1 null genotype in their profiles. No such characteristic feature could be attributed to the equal number of profiles that were solely represented by the control group. Combined analysis of phase I and phase II detoxification systems revealed a greater association of the high-risk genotypes of at least one phase I enzymes in combination with one or more phase II enzymes with RM. This reflected the importance of balance in the two biotransformation systems, the absence of which may be a contributing factor to the etiology of recurrent miscarriages.
Discussion
In the present study, we attempted to study the effect of phase I and phase II detoxification gene polymorphisms on recurrent miscarriages among North Indian women. This is the first report from this part of the country. Apart from the established risk factors, detoxification mechanisms may also play an important role in influencing the success of pregnancy outcome. A deficient decidual or placental detoxification system, resulting in increased exposure of the conceptus to endo-or exogenous toxins may lead to the development of early pregnancy loss. Many reports indicate the importance of Cytochrome P-450 enzymes in human reproduction (Baranova et al., 1999; Hadfield et al., 2001; Chen et al., 2002) . The GST family of enzymes, on the other hand is believed to exert a critical role in cellular protection against toxic foreign chemicals and oxidative stress (Hayes and Strange 2000) . For this study, we have selected two major enzymes The difference in frequencies between the case and control groups was analyzed for statistical significance at the 95% confidence interval using Fisher's exact test with Bonferroni correction. Odds ratios (ORs) were calculated and reported within the 95% confidence limits. Logistic regression analysis was performed with different genotypes as well as genotype combinations as the independent factors, with the risk of RM being the dependent variable.
involved in phase I (CYP1A1 and CYP2D6) and three GST isoforms (GSTT1, GSTP1 and GSTM1) of phase II for their known polymorphisms and their influence on the outcome of pregnancy. Our findings favor the protective role of the wild-type CYP1A1 allele in the maintenance of pregnancy. We found an increased incidence of 2D6*4 allele carriage among patients. Upon combined analysis of phase I genes, we observed that the combination of wild-type 2D6 (wt/wt) and 1A1 (ile/ile) was more prevalent among controls (53.3%) than in patients (31.5%). This may contribute to the maintenance of a successful pregnancy by the combined effects of reduced generation of reactive free radicals by CYP1A1 on one hand, and increased detoxification of environmental pollutants and xenobiotic compounds by the normal CYP2D6 (EM; wt/wt) on the other. The activated compounds generated by the phase I enzymes are further subjected to detoxification by the phase II enzymes, especially the GSTs. In the present study, we found no significant association of Genetic variability in detoxification genes and RM GSTM1 null genotype or GSTP1 mutants with the recurrent miscarriage in North Indian population. There was however, strong association of GSTT1 null genotypes with the patients both when studied alone and also when analyzed in combination with GSTM1 null and GSTP1 mutant genotypes resulting, into an increased risk of 4-fold in both cases and a greater than 7-fold risk when all the three variant phase II genotypes were present. Upon combined analysis of phase I and phase II gene systems, we observed that the genotypic profiles consisting of at least one high-risk phase I allele in combination with one or more high-risk phase II variants renders high susceptibility to experiencing RM among individuals, emphasizing the importance of balance in the phase I/phase II detoxification systems in the maintenance of a successful pregnancy. The phase I and phase II variants included in this study have been extensively characterized previously in various populations and disease association studies. These genetic polymorphisms have been shown to vary considerably between different ethnic groups. The CYP1A1*2A homozygous variant genotype has been detected at higher frequencies in Asians (4-13%) and African-Americans (6-7%) but at lower frequencies in Northern Europeans and European-Americans (0-2%) Raunio et al., 1995) . The prevalence of CYP2D6 poor metabolizers, on the other hand is approximately 6-10% amongst white populations, but is lower in most other ethnic groups such as Asians (2%) (Droll et al., 1998) . The null genotype of GSTT1 is found in 15 -40% of Caucasians and 50 -60% of Asians. On the other hand, about half of both Japanese and Caucasians and 30% of Africans are homozygous for the GSTM1 null (Bolt and Thier, 2006) . The GSTP1 ile105val homozygous and heterozygous frequencies respectively in different ethnic groups studied are as follows: 18.9 and 49% in African-Americans (Manar et al., 2004) , 16.4 and 43.8% in Caucasians (Fryer et al., 2000) , 1-4 and 29% in Asians (Sharifi et al., 2008) and 7 and 45% in Europeans .
Prior to this, there have only been a few studies where phase I and phase II gene polymorphisms have been investigated for RM and the results too demonstrate ethnic variability in this context. Variation in the phase II gene GSTP1 has been found to be associated with RM in Caucasians (Zusterzeel et al., 2000) , whereas studies in Japanese population show an association of GSTM1 null genotypes with RM (Sata et al., 2003b) and no association with other genes has been found (Sata et al., 2003b; Saijo et al., 2004a, b) . On the other hand an association with the variant CYP1A1 has been shown with RM among South Indians (Suryanarayana et al., 2004) . The present study conducted among North Indian subjects revealed an association between the presence of variant alleles of CYP1A1 and CYP2D6 and the GSTT1 null genotype and the risk of recurrent early pregnancy loss. These results could not be considered as a contradiction to the previous studies. The effect on the balance of phase I/phase II systems can be either because of the over activity of a CYP1A1 variant or due to the inefficient clearance of reactive species and xenobiotics by the phase II gene variants. The data adds to the importance of ethnic as well as intra-regional variability in pharmacogenomic studies.
Understanding the basis of observed genetic associations is complicated because of the large number of genes involved in the detoxification systems and the complex functional interactions of the gene products. There is extensive diversity among these genes which differ not only in their nucleotide sequences, but also have a wide geo-ethnic distribution. This is the first study of North Indians demonstrating the involvement of detoxification gene polymorphisms and their effect on the balance of the two biotransformation systems in recurrent fetal loss. Further assessment related to the expression of these genes in the context of pregnancy and environmental stress may help in elucidating the precise regulatory mechanisms of these systems and their interplay in the maintenance of a successful pregnancy.
